Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the covid-19 outbreak on the number of patients receiving treatment for Kawasaki disease in (a) Wales and (b) the UK.

The Department only holds data for activity in England as health is a devolved matter. The Department, alongside NHS England, continues to consider the impact of COVID-19 on patients with Kawasaki disease and other rare diseases.

NHS England has had discussions with some services and patients/patient groups to understand the impact of COVID-19. NHS England has worked with commissioned providers, patient groups and charities throughout the pandemic to ensure that patients, carers and their families have been supported during the COVID-19 outbreak and ensuring those discussions inform planning for autumn and winter.